Global HbA1c Testing Device Market

HbA1c Testing Device Comprehensive Study by Type (Handheld Device, Bench-top Device), Application (Hospital, Homecare, Diagnostic laboratory, Research Institutions), Technology (Ion-exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, Other) Players and Region - Global Market Outlook to 2028

HbA1c Testing Device Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About HbA1c Testing Device
HbA1c test is useful to screen & diagnose for diabetes as well as prediabetes in patients. Hemoglobin molecule from the blood cell sticks to the glucose which upsurge glycosylated hemoglobin molecule called as hemoglobin A1C (HbA1C). Around the globe, patients with high glucose level have more HbA1C present in their blood. Average blood glucose level of a person can be identified by measuring this glycosylated hemoglobin molecule. HbA1c test is considered more real than checking the blood glucose level. HbA1c Testing Devices are used for the HbA1c test. Rapidly growing diabetic patient population base, along with growing geriatric and overweight population around the globe is likely to impel the growth of global HbA1c Testing Device market over coming years.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia-Pacific
UnitValue (USD Billion)


Analyst at AMA Research estimates that German, Japanese and United States Players will contribute the maximum growth to Global HbA1c Testing Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Siemens AG (Germany), Tosoh Corporation (Japan), Danaher Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Trinity Biotech Plc.(Republic of Ireland), Arkray Group (Japan) and OSANG HEALTHCARE CO., LTD (South Korea) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Polymer Technology Systems, Inc. (United States), GREEN CROSS CORP. (South Korea) and ERBA Diagnostics (United States).

Segmentation Overview
AMA Research has segmented the market of Global HbA1c Testing Device market by Type (Handheld Device and Bench-top Device), Application (Hospital, Homecare, Diagnostic laboratory and Research Institutions) and Region. On the basis of Type, Bench-top Device are dominating the market in the year 2022

On the basis of application, Diagnostic laboratory segment is dominating the market in the year 2022

On the basis of geography, the market of HbA1c Testing Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Ion-exchange HPLC will boost the HbA1c Testing Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
Rapidly growing Diabetic Patient Population Base, Growing geriatric and overweight population and Growing healthcare expenditure over diabetes management

Restraints:
High cost of device

Opportunities:
Untapped market such as developing countries and growing medical tourism




Key Target Audience
HbA1c Testing Device manufacturers, Raw material suppliers, Government and research organizations, Distribution consultancies, Hospital, Homecare and Diagnostic laboratory

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Handheld Device
  • Bench-top Device
By Application
  • Hospital
  • Homecare
  • Diagnostic laboratory
  • Research Institutions
By Technology
  • Ion-exchange HPLC
  • Enzymatic Assay
  • Affinity Binding Chromatography
  • Turbidimetric Inhibition Immunoassay
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapidly growing Diabetic Patient Population Base
      • 3.2.2. Growing geriatric and overweight population
      • 3.2.3. Growing healthcare expenditure over diabetes management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global HbA1c Testing Device, by Type, Application, Technology and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global HbA1c Testing Device (Value)
      • 5.2.1. Global HbA1c Testing Device by: Type (Value)
        • 5.2.1.1. Handheld Device
        • 5.2.1.2. Bench-top Device
      • 5.2.2. Global HbA1c Testing Device by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Homecare
        • 5.2.2.3. Diagnostic laboratory
        • 5.2.2.4. Research Institutions
      • 5.2.3. Global HbA1c Testing Device by: Technology (Value)
        • 5.2.3.1. Ion-exchange HPLC
        • 5.2.3.2. Enzymatic Assay
        • 5.2.3.3. Affinity Binding Chromatography
        • 5.2.3.4. Turbidimetric Inhibition Immunoassay
        • 5.2.3.5. Other
      • 5.2.4. Global HbA1c Testing Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. HbA1c Testing Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tosoh Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Trinity Biotech Plc.(Republic of Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Arkray Group (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. OSANG HEALTHCARE CO., LTD (South Korea)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global HbA1c Testing Device Sale, by Type, Application, Technology and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global HbA1c Testing Device (Value)
      • 7.2.1. Global HbA1c Testing Device by: Type (Value)
        • 7.2.1.1. Handheld Device
        • 7.2.1.2. Bench-top Device
      • 7.2.2. Global HbA1c Testing Device by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Homecare
        • 7.2.2.3. Diagnostic laboratory
        • 7.2.2.4. Research Institutions
      • 7.2.3. Global HbA1c Testing Device by: Technology (Value)
        • 7.2.3.1. Ion-exchange HPLC
        • 7.2.3.2. Enzymatic Assay
        • 7.2.3.3. Affinity Binding Chromatography
        • 7.2.3.4. Turbidimetric Inhibition Immunoassay
        • 7.2.3.5. Other
      • 7.2.4. Global HbA1c Testing Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. HbA1c Testing Device: by Type(USD Billion)
  • Table 2. HbA1c Testing Device Handheld Device , by Region USD Billion (2017-2022)
  • Table 3. HbA1c Testing Device Bench-top Device , by Region USD Billion (2017-2022)
  • Table 4. HbA1c Testing Device: by Application(USD Billion)
  • Table 5. HbA1c Testing Device Hospital , by Region USD Billion (2017-2022)
  • Table 6. HbA1c Testing Device Homecare , by Region USD Billion (2017-2022)
  • Table 7. HbA1c Testing Device Diagnostic laboratory , by Region USD Billion (2017-2022)
  • Table 8. HbA1c Testing Device Research Institutions , by Region USD Billion (2017-2022)
  • Table 9. HbA1c Testing Device: by Technology(USD Billion)
  • Table 10. HbA1c Testing Device Ion-exchange HPLC , by Region USD Billion (2017-2022)
  • Table 11. HbA1c Testing Device Enzymatic Assay , by Region USD Billion (2017-2022)
  • Table 12. HbA1c Testing Device Affinity Binding Chromatography , by Region USD Billion (2017-2022)
  • Table 13. HbA1c Testing Device Turbidimetric Inhibition Immunoassay , by Region USD Billion (2017-2022)
  • Table 14. HbA1c Testing Device Other , by Region USD Billion (2017-2022)
  • Table 15. South America HbA1c Testing Device, by Country USD Billion (2017-2022)
  • Table 16. South America HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 17. South America HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 18. South America HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 19. Brazil HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 20. Brazil HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 21. Brazil HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 22. Argentina HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 23. Argentina HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 24. Argentina HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 25. Rest of South America HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 26. Rest of South America HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 27. Rest of South America HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 28. Asia Pacific HbA1c Testing Device, by Country USD Billion (2017-2022)
  • Table 29. Asia Pacific HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 30. Asia Pacific HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 31. Asia Pacific HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 32. China HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 33. China HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 34. China HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 35. Japan HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 36. Japan HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 37. Japan HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 38. India HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 39. India HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 40. India HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 41. South Korea HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 42. South Korea HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 43. South Korea HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 44. Taiwan HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 45. Taiwan HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 46. Taiwan HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 47. Australia HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 48. Australia HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 49. Australia HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 50. Rest of Asia-Pacific HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 51. Rest of Asia-Pacific HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 52. Rest of Asia-Pacific HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 53. Europe HbA1c Testing Device, by Country USD Billion (2017-2022)
  • Table 54. Europe HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 55. Europe HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 56. Europe HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 57. Germany HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 58. Germany HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 59. Germany HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 60. France HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 61. France HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 62. France HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 63. Italy HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 64. Italy HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 65. Italy HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 66. United Kingdom HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 67. United Kingdom HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 68. United Kingdom HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 69. Netherlands HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 70. Netherlands HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 71. Netherlands HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 72. Rest of Europe HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 73. Rest of Europe HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 74. Rest of Europe HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 75. MEA HbA1c Testing Device, by Country USD Billion (2017-2022)
  • Table 76. MEA HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 77. MEA HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 78. MEA HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 79. Middle East HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 80. Middle East HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 81. Middle East HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 82. Africa HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 83. Africa HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 84. Africa HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 85. North America HbA1c Testing Device, by Country USD Billion (2017-2022)
  • Table 86. North America HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 87. North America HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 88. North America HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 89. United States HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 90. United States HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 91. United States HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 92. Canada HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 93. Canada HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 94. Canada HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 95. Mexico HbA1c Testing Device, by Type USD Billion (2017-2022)
  • Table 96. Mexico HbA1c Testing Device, by Application USD Billion (2017-2022)
  • Table 97. Mexico HbA1c Testing Device, by Technology USD Billion (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. HbA1c Testing Device: by Type(USD Billion)
  • Table 108. HbA1c Testing Device Handheld Device , by Region USD Billion (2023-2028)
  • Table 109. HbA1c Testing Device Bench-top Device , by Region USD Billion (2023-2028)
  • Table 110. HbA1c Testing Device: by Application(USD Billion)
  • Table 111. HbA1c Testing Device Hospital , by Region USD Billion (2023-2028)
  • Table 112. HbA1c Testing Device Homecare , by Region USD Billion (2023-2028)
  • Table 113. HbA1c Testing Device Diagnostic laboratory , by Region USD Billion (2023-2028)
  • Table 114. HbA1c Testing Device Research Institutions , by Region USD Billion (2023-2028)
  • Table 115. HbA1c Testing Device: by Technology(USD Billion)
  • Table 116. HbA1c Testing Device Ion-exchange HPLC , by Region USD Billion (2023-2028)
  • Table 117. HbA1c Testing Device Enzymatic Assay , by Region USD Billion (2023-2028)
  • Table 118. HbA1c Testing Device Affinity Binding Chromatography , by Region USD Billion (2023-2028)
  • Table 119. HbA1c Testing Device Turbidimetric Inhibition Immunoassay , by Region USD Billion (2023-2028)
  • Table 120. HbA1c Testing Device Other , by Region USD Billion (2023-2028)
  • Table 121. South America HbA1c Testing Device, by Country USD Billion (2023-2028)
  • Table 122. South America HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 123. South America HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 124. South America HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 125. Brazil HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 126. Brazil HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 127. Brazil HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 128. Argentina HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 129. Argentina HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 130. Argentina HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 131. Rest of South America HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 132. Rest of South America HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 133. Rest of South America HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 134. Asia Pacific HbA1c Testing Device, by Country USD Billion (2023-2028)
  • Table 135. Asia Pacific HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 136. Asia Pacific HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 137. Asia Pacific HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 138. China HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 139. China HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 140. China HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 141. Japan HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 142. Japan HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 143. Japan HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 144. India HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 145. India HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 146. India HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 147. South Korea HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 148. South Korea HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 149. South Korea HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 150. Taiwan HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 151. Taiwan HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 152. Taiwan HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 153. Australia HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 154. Australia HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 155. Australia HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 156. Rest of Asia-Pacific HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 157. Rest of Asia-Pacific HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 158. Rest of Asia-Pacific HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 159. Europe HbA1c Testing Device, by Country USD Billion (2023-2028)
  • Table 160. Europe HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 161. Europe HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 162. Europe HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 163. Germany HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 164. Germany HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 165. Germany HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 166. France HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 167. France HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 168. France HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 169. Italy HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 170. Italy HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 171. Italy HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 172. United Kingdom HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 173. United Kingdom HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 174. United Kingdom HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 175. Netherlands HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 176. Netherlands HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 177. Netherlands HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 178. Rest of Europe HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 179. Rest of Europe HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 180. Rest of Europe HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 181. MEA HbA1c Testing Device, by Country USD Billion (2023-2028)
  • Table 182. MEA HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 183. MEA HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 184. MEA HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 185. Middle East HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 186. Middle East HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 187. Middle East HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 188. Africa HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 189. Africa HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 190. Africa HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 191. North America HbA1c Testing Device, by Country USD Billion (2023-2028)
  • Table 192. North America HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 193. North America HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 194. North America HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 195. United States HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 196. United States HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 197. United States HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 198. Canada HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 199. Canada HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 200. Canada HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 201. Mexico HbA1c Testing Device, by Type USD Billion (2023-2028)
  • Table 202. Mexico HbA1c Testing Device, by Application USD Billion (2023-2028)
  • Table 203. Mexico HbA1c Testing Device, by Technology USD Billion (2023-2028)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global HbA1c Testing Device: by Type USD Billion (2017-2022)
  • Figure 5. Global HbA1c Testing Device: by Application USD Billion (2017-2022)
  • Figure 6. Global HbA1c Testing Device: by Technology USD Billion (2017-2022)
  • Figure 7. South America HbA1c Testing Device Share (%), by Country
  • Figure 8. Asia Pacific HbA1c Testing Device Share (%), by Country
  • Figure 9. Europe HbA1c Testing Device Share (%), by Country
  • Figure 10. MEA HbA1c Testing Device Share (%), by Country
  • Figure 11. North America HbA1c Testing Device Share (%), by Country
  • Figure 12. Global HbA1c Testing Device share by Players 2022 (%)
  • Figure 13. Global HbA1c Testing Device share by Players (Top 3) 2022(%)
  • Figure 14. Global HbA1c Testing Device share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 18. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2022
  • Figure 20. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Siemens AG (Germany) Revenue: by Geography 2022
  • Figure 22. Tosoh Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Tosoh Corporation (Japan) Revenue: by Geography 2022
  • Figure 24. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 26. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Trinity Biotech Plc.(Republic of Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Trinity Biotech Plc.(Republic of Ireland) Revenue: by Geography 2022
  • Figure 30. Arkray Group (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Arkray Group (Japan) Revenue: by Geography 2022
  • Figure 32. OSANG HEALTHCARE CO., LTD (South Korea) Revenue, Net Income and Gross profit
  • Figure 33. OSANG HEALTHCARE CO., LTD (South Korea) Revenue: by Geography 2022
  • Figure 34. Global HbA1c Testing Device: by Type USD Billion (2023-2028)
  • Figure 35. Global HbA1c Testing Device: by Application USD Billion (2023-2028)
  • Figure 36. Global HbA1c Testing Device: by Technology USD Billion (2023-2028)
  • Figure 37. South America HbA1c Testing Device Share (%), by Country
  • Figure 38. Asia Pacific HbA1c Testing Device Share (%), by Country
  • Figure 39. Europe HbA1c Testing Device Share (%), by Country
  • Figure 40. MEA HbA1c Testing Device Share (%), by Country
  • Figure 41. North America HbA1c Testing Device Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Siemens AG (Germany)
  • Tosoh Corporation (Japan)
  • Danaher Corporation (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Trinity Biotech Plc.(Republic of Ireland)
  • Arkray Group (Japan)
  • OSANG HEALTHCARE CO., LTD (South Korea)
Additional players considered in the study are as follows:
Polymer Technology Systems, Inc. (United States) , GREEN CROSS CORP. (South Korea) , ERBA Diagnostics (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 201 Pages 72 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global HbA1c Testing Device Market Quantitative research analysis
Global HbA1c Testing Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Siemens AG (Germany), Tosoh Corporation (Japan), Danaher Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Trinity Biotech Plc.(Republic of Ireland), Arkray Group (Japan) and OSANG HEALTHCARE CO., LTD (South Korea) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for HbA1c Testing Device Market during projected period 2022-2028.
The HbA1c Testing Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates HbA1c Testing Device Market to reach USD2.38 Billion by 2028.

Know More About Global HbA1c Testing Device Market Report?

Have a Query? Click Here

Other Related Reports

Nasal Spray Comprehensive Study by Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution, Saline Nasal Spray, Others), Application (Asthma, Nasal Congestion, Allergic and Non-Aller...
$ 3750
Medical Loupes Comprehensive Study by Application (Dental Clinics, Hospitals, Other) Players and Region - Global Market Outlook to 2026
$ 3500
Medical Monitor Comprehensive Study by Type (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Remote Patient Monitoring Devices, Cardiac Monitoring Devices, Mu...
$ 3750
Refractive Surgery Devices Comprehensive Study by End-users (Hospitals, Ophthalmic Clinics, Others), Product Type (Lasers, Excimer Lasers, Femtosecond Lasers, Flaps, Aberrometers, Others), Surgery (C...
$ 3350
Dental Delivery Systems Comprehensive Study by Application (Hospital, Ambulatory Surgical Centers, Dental Clinics), Modality (Fixed Dental Delivery Systems, Rear-delivery Systems, Side-delivery Syste...
$ 3650
Amblyopia Therapeutic Apparatus Comprehensive Study by Type (Color/Icon Apparatus, Comprehensive Apparatus), Application (Home Care, Hospitals, Ophthalmologic Center), Distribution Channel (Online Ch...
$ 3350